Helen M. Thackray - Chief R&D Officer at BIOCRYST PHARMACEUTICALS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Issuer Symbol
BCRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Helen M. Thackray since 12 Feb 2025

Holdings reported by Helen M. Thackray for BIOCRYST PHARMACEUTICALS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 377,318 $2,829,885 $7.50 31 Mar 2025 Direct
Emp. Stock Option (Right to Buy) 260,950 19 Dec 2024 Direct Common Stock

Transactions reported by Helen M. Thackray for BIOCRYST PHARMACEUTICALS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.